CDH1 and breast carcinoma: Besides, it has been verified that DACH1 could suppress epithelial-mesenchymal transition (EMT), migration, metastasis by antagonizing YB-1-mediated transcriptional events, SNAI1-E-cadherin pathway, and IL-8 transcription in breast cancer cells [39–41].